Table:
hearing loss vs bumetanide and bumetanide + aminoglycoside therapy for the 26 surviving treated neonates in the Boston neonatal seizure trial3.
| Hearing loss | No hearing loss | |
|---|---|---|
| bumetanide | 0 | 12 |
| Aminoglycoside + bumetanide | 2 | 12 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.